Panel discussions will address sustainability and the crossover between food and pharma
President and CEO, BI Nutraceuticals
George Pontiakos, President and CEO of BI Nutraceuticals, will be participating in two panel discussions at the Nutrition Integrates 2014 conference being held on 5 June at the Grange Tower Bridge, London, UK.
The first of these, “Sustainability Expands Beyond Simple Carbon Footprint: Going Green, Ethical Sourcing and Protecting the Planet”, will take place from 10:55–11:50 a.m. and will address protecting marine ecosystems from over-fishing, functional ingredients derived from byproducts and alternative sources and how to achieve environmental excellence throughout the supply chain.
Other panel members include Tim Finnigan, Director of Research & Development, Quorn Foods, Adam Ismail, Executive Director, GOED, Mike Mitchell, Group Technical and CSR Director Young’s Seafood, and Jacob Thundil, Director, Cocofina.
The second panel discussion, “Industry Convergence: Crossing the Food vs Pharma Divide”, will be held from 3:30–4:25 p.m. and will highlight how patient power is driving prevention trends, keys to achieving GMP compliant manufacturing and the role of Big Pharma in consumer healthcare.
Additional panel participants include Rowena Pullan, Vice President Global Franchise R&D, Dietary Supplements & Complementary Categories, Pfizer Consumer Health; Rob Beudeker, Vice President Innovation Human Nutrition and Health, DSM Nutritional Products; and Cathie Martin, Group Leader, John Innes Centre & Professor, Department Metabolic Biology, University of East Anglia.
Nutrition Integrates brings together key stakeholders from the nutrition, health and wellness industries, science and academia to facilitate strategic debate and enhance working relationships. Nutrition Integrates 2014 will attract up to 150 senior European nutrition and health executives largely comprised of leading food and beverage manufacturers, retailers, academia, regulatory bodies, distributors and ingredient suppliers to discuss the critical challenges and issues facing the European nutrition, health and wellness industries.
As president and CEO of BI Nutraceuticals, Pontiakos oversees all aspects of operations for west and east coast offices, and the Zuellig Group Nutrition and Ingredients, China. He has held senior leadership positions at several leading consulting, medical services and technology companies including Monovasia, which he founded, Oluma, Lucent, Agere, Ortel, NetVantage and Timeplex.
He has wide-ranging experience in scaling geographically dispersed global companies to maximise their ability to successfully compete in the marketplace. Pontiakos holds a bachelor’s degree in Business Management from Farleigh Dickinson University, New Jersey.